https://www.pharmaceutical-technology.com/data-insights/immunogen-files-patent-for-combination-therapy-for-hematological-malignancies-using-immunoconjugates/
Discover ImmunoGen Inc.'s groundbreaking patent for innovative immunoconjugate therapies targeting CD123 in hematologic malignancies. Learn about effective...
patent combinationhematological malignanciesimmunogeninctherapy
https://www.fool.com/investing/2021/12/01/why-immunogen-stock-is-flying-high-today/
The biotech is continuing to surge after after a late-stage win in treatment for advanced ovarian cancer.
flying highmotley foolimmunogenstocktoday
https://www.fool.com/investing/2019/02/12/immunogen-still-waiting-to-take-its-leap-forward.aspx
Data from a late-stage clinical trial is expected in the first half of this year.
still waitingleap forwardimmunogentakemotley
https://www.pharmaceutical-technology.com/news/newsdeals-this-week-organovo-thermo-fisher-scientific-immunogen-4924581/
Organovo Holdings and University of California, San Francisco, (UCSF) have entered a partnership to develop 3D Bioprinted Tissues for skeletal disease research.
thermo fisher scientificpharmaceutical technologydealsweekorganovo